Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is a modern type of cancer therapy that unites hyperthermic in vivo chemotherapy with cytoreductive abdominal surgery. It is applied to selected cancers, which have moved to the abdomen lining or the peritoneum.
HIPEC being a big procedure is however not suitable amongst all patients. Physicians should understand whether or not the cancer can be properly excised and they must make sure that the patient is physically fit to withstand an extensive surgery.
No one single checklist automatically excludes any patients. It is contingent on the type and stage of cancer, the overall health and the ability to reach effective cytoreduction.
Who May Not Be a Candidate for HIPEC?
A patient does not necessarily qualify to undergo HIPEC when the chances of significantly risky surgery greatly exceed the anticipated probabilities of success.
The following are some of the essential factors:
- Extensive cancer spread outside the abdominal cavity
- Very extensive peritoneal disease
- Widespread small bowel involvement
- Poor overall physical condition
- Serious uncontrolled medical conditions
- Cancer types where HIPEC has no established role
- Inability to achieve adequate tumour removal
A specialist team generally evaluates these factors together rather than making a decision based on one factor alone.
Extensive Cancer Spread Outside the Abdomen
HIPEC is primarily intended to treat cancer within the abdominal cavity. If the disease has spread extensively to distant organs, treating the abdominal disease alone may not provide sufficient benefit. For example, widespread metastases involving organs such as the lungs or bones may make a patient unsuitable for CRS-HIPEC.
However, this does not mean every patient with disease outside the abdomen is automatically excluded. The significance of distant disease depends on the cancer type, number and location of metastases and whether they can also be treated effectively.
Very Extensive Peritoneal Disease
The amount and distribution of cancer inside the abdomen are important considerations.
Doctors may use the Peritoneal Cancer Index (PCI) to assess the extent of peritoneal disease. A high PCI can indicate widespread tumour deposits and may make complete cytoreductive surgery difficult or impossible.
Why Complete Tumour Removal Matters:
The objective of cytoreductive surgery is to remove visible tumour deposits as completely as possible before HIPEC is administered.
HIPEC may not be recommended when:
- Disease is too widespread to remove adequately.
- Tumour deposits are located in areas where safe removal is not possible.
- Complete or near-complete cytoreduction is unlikely.
- The expected surgical risks are greater than the potential benefit.
PCI thresholds can vary according to cancer type, so the score should always be interpreted by an experienced HIPEC team.
Extensive Small Bowel Involvement
Extensive cancer involving the small intestine can be another limiting factor. Removing multiple affected sections of the bowel may leave insufficient functioning intestine. In addition, disease involving several areas of the small bowel can make complete cytoreduction technically difficult.
For this reason, surgeons carefully assess the location and extent of small bowel disease before recommending HIPEC.
Poor General Health and Physical Fitness
HIPEC involves major abdominal surgery and can require a lengthy recovery. Patients therefore need sufficient physical reserve to tolerate the procedure.
Doctors may be cautious about recommending HIPEC for patients with:
- Severe heart or lung disease
- Significant kidney dysfunction
- Severe frailty
- Poor nutritional status
- Very limited physical capacity
- Other serious uncontrolled medical conditions
Importantly, age alone does not necessarily make someone ineligible. A physically fit older patient may be considered differently from a younger patient with serious medical problems.
The patient’s overall health and ability to recover from major surgery are more important than age in isolation.
Active Infection or Uncontrolled Health Problems
An active infection or poorly controlled medical condition may require treatment before major cancer surgery can be considered.
For instance, a patient with poor nutritional status may first need nutritional support. Similarly, an infection or uncontrolled medical condition may need to be managed before surgery.
Eligibility Can Sometimes Change
Not being considered suitable at one point does not always mean that HIPEC will never be possible.
In selected cases, a patient’s condition may improve after:
- Treating an active infection
- Improving nutritional status
- Increasing physical fitness
- Managing other medical conditions
- Using systemic therapy to control or reduce tumour burden
The patient can then be reassessed by the treating team.
Cancer Type and Treatment History Matter
HIPEC is not a standard treatment for every cancer that spreads to the peritoneum. Its potential role depends on the type and biology of the cancer and the evidence supporting its use.
Previous treatments also matter. Doctors may review chemotherapy received, previous surgeries, response to treatment and the current pattern of disease before determining whether CRS-HIPEC is appropriate.
This is why a patient should not assume that having peritoneal metastases automatically makes them a candidate for HIPEC.
How Is HIPEC Eligibility Determined?
A specialist team generally reviews the patient’s complete medical picture before making a recommendation.
The assessment may include:
- CT or MRI scans
- PET imaging where appropriate
- Pathology reports
- Previous treatment records
- Blood tests and organ-function assessment
- Evaluation of nutritional and physical status
- Assessment of the extent of peritoneal disease
- PCI assessment
- In some cases, diagnostic laparoscopy
The team then considers whether adequate cytoreduction is achievable and whether the expected benefits justify the risks of the procedure.
What About HIPEC Surgery Cost in India?
The HIPEC Surgery cost in India varies from patient to patient. It can depend on the cancer type, extent of disease, complexity of surgery, hospital stay, medicines, investigations, surgeon and multidisciplinary care required.
Therefore, patients should be cautious about relying on a single fixed online price. A personalised estimate is more meaningful after the medical team reviews scans, pathology and previous treatment records.
Cost is important, but the experience of the HIPEC team and the hospital’s ability to provide complex postoperative care should also be considered.
Finding a HIPEC Specialist in Ahemdabad
Patients searching for a HIPEC Specialist in Ahemdabad should consider a surgical oncology team with experience in cytoreductive surgery and HIPEC.
During a consultation, patients can ask:
- Is my cancer type suitable for HIPEC?
- How extensive is my peritoneal disease?
- What is my PCI score, if applicable?
- Can the visible tumour be removed adequately?
- What are the potential risks?
- What alternatives are available if HIPEC is not recommended?
For people considering HIPEC Surgery in Ahmedabad, obtaining an assessment from an experienced specialist can help them understand whether the procedure is appropriate for their specific situation.
What If HIPEC Is Not Recommended?
Being unsuitable for HIPEC does not mean that treatment options have ended. Depending on the cancer type and individual condition, doctors may consider systemic chemotherapy, targeted therapy, immunotherapy where appropriate, other specialised procedures or supportive and palliative treatments.
Some patients may also become candidates for another treatment approach after their disease or overall health changes.
Patients seeking HIPEC treatment in Ahmedabad should therefore focus on getting an individualised treatment plan rather than trying to determine eligibility from symptoms or online criteria alone.
Consult Dr. Aditi for HIPEC Surgery in Ahmedabad
If you or a loved one is considering HIPEC surgery, consulting an experienced surgical oncology specialist can help you understand the available treatment options. Dr. Aditi can be promoted as a point of contact for patients seeking guidance on HIPEC eligibility, cytoreductive surgery and personalised cancer treatment planning in Ahmedabad.
During a consultation, patients can discuss their cancer type, the extent of peritoneal disease, previous treatments and overall fitness for major surgery. A specialist assessment can help determine whether HIPEC may be appropriate or whether another treatment approach would be more suitable.
Patients exploring HIPEC treatment in Ahmedabad should bring their latest scans, pathology reports, blood test results and previous treatment records to the consultation. These details can help the treating team evaluate the potential benefits and risks of the procedure and explain the next steps.
If you are unsure whether HIPEC is a suitable option, consider scheduling a consultation with Dr. Aditi to discuss your individual condition and make an informed decision about your cancer care.